STAT September 19, 2022
Ambar Castillo

Rep. Robin Kelly admits that the word “diversity” has scared some of her Republican colleagues away from her effort to improve representation in clinical trials.

“It’s been a little tough on the other side of the aisle,” Kelly said at a recent STAT event. “I don’t want to put one broad brush on everybody, but … they feel like the government’s putting their nose in something a little bit too much.”

The Illinois Democrat has already managed to get one GOP co-sponsor on board with her bill, the NIH Clinical Trial Diversity Act of 2022, which would require clinical trial sponsors to write formal diversity plans when they apply for funding from the National Institutes of Health. If it passes,...

Today's Sponsors

Zelis
HealthITq
Premier

Today's Sponsors

Upfront Healthcare
pCare

Today's Sponsor

Curation Health

 
Topics: Clinical Trials, Congress / White House, Equity/SDOH, Govt Agencies, Healthcare System, Regulations, Trends
Claims That RSV Surge Due To Covid-19 Vaccines Take Clinical Trial Data Out Of Context
How Clinical Trials Can Thrive in the Digital Era
Clinical Trial Management Systems and Compliance
Viz.ai partners with Vastrax to expedite enrolment in clinical trials
OncoBay signs on with physIQ's latest clinical trial partner program